$9.10
6.09% yesterday
Nasdaq, Jun 13, 10:00 pm CET
ISIN
US23306J1016
Symbol
DBVT
Sector
Industry

DBV Technologies SA Sponsored ADR Stock price

$9.10
-1.89 17.20% 1M
+5.53 154.90% 6M
+6.01 194.50% YTD
+3.95 76.70% 1Y
-45.80 83.42% 5Y
-263.30 96.66% 10Y
-219.90 96.03% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
-0.59 6.09%
ISIN
US23306J1016
Symbol
DBVT
Sector
Industry

Key metrics

Market capitalization $259.87m
Enterprise Value $234.36m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 56.47
P/S ratio (TTM) P/S ratio 62.62
P/B ratio (TTM) P/B ratio 34.08
Revenue growth (TTM) Revenue growth -73.62%
Revenue (TTM) Revenue $4.15m
EBIT (operating result TTM) EBIT $-116.48m
Free Cash Flow (TTM) Free Cash Flow $-105.52m
Cash position $32.46m
EPS (TTM) EPS $-1.18
P/S forward 87.44
EV/Sales forward 78.86
Short interest 0.10%
Show more

Is DBV Technologies SA Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

DBV Technologies SA Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a DBV Technologies SA Sponsored ADR forecast:

4x Buy
80%
1x Sell
20%

Analyst Opinions

5 Analysts have issued a DBV Technologies SA Sponsored ADR forecast:

Buy
80%
Sell
20%

Financial data from DBV Technologies SA Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
4.15 4.15
74% 74%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 31 31
1% 1%
752%
- Research and Development Expense 85 85
19% 19%
2,053%
-112 -112
29% 29%
-2,705%
- Depreciation and Amortization 4.23 4.23
139% 139%
102%
EBIT (Operating Income) EBIT -116 -116
53% 53%
-2,807%
Net Profit -114 -114
57% 57%
-2,750%

In millions USD.

Don't miss a Thing! We will send you all news about DBV Technologies SA Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DBV Technologies SA Sponsored ADR Stock News

Neutral
GlobeNewsWire
2 days ago
Châtillon, France, June 12, 2025 DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today announced upcoming participation in the European Academy of Allergy and Clinical Immunology (EAACI) Congress, June 13 – 16, 2025, in Glasgow, United...
Neutral
GlobeNewsWire
3 days ago
Châtillon, France, June 11, 2025 DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company (the “Company”), held its Combined General Meeting (the “General Meeting”). The General Meeting was chaired ...
Neutral
GlobeNewsWire
11 days ago
Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company (the “Company”), today announced today the filing of an addendum to the 2024 Universal Registration Document (the “Addendum”) with the French...
More DBV Technologies SA Sponsored ADR News

Company Profile

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. It focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.

Head office France
CEO Daniel Tassé
Employees 110
Founded 2002
Website www.dbv-technologies.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today